North Dakota Healthcare Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Dakota Healthcare Newswire.

Press releases published on November 12, 2026

9 hours ago

Vivani Medical Announces Positive Top-Line Results from SLIM-1™, a First in Human Phase 1 Trial of NPM-139 (semaglutide implant) and Wegovy (weekly semaglutide injections) in Obese and Overweight Subjects

Indeterminate GlobeNewswire

9 hours ago

Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference 2026 in London

Indeterminate GlobeNewswire

9 hours ago

R1 Takes Aim at Healthcare’s Fragmented Revenue Cycle with Six Connected AI Solutions

Indeterminate GlobeNewswire

9 hours ago

Biolojic Design Receives U.S. FDA Clearance of Investigational New Drug (IND) Application for BD200, the First Multibody to Enter Clinical Trials

Indeterminate GlobeNewswire

9 hours ago

123Dentist CEO Jeff Leger and family establish fund at Dalhousie University’s Faculty of Dentistry to advance research into the connection between oral health and overall health

Indeterminate GlobeNewswire

9 hours ago

Jeff Leger, président-directeur général de 123Dentiste, et sa famille créent un fonds à la Faculté de médecine dentaire de l’Université Dalhousie pour mieux comprendre le lien entre santé buccodentaire et santé globale

Indeterminate GlobeNewswire

9 hours ago

Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

9 hours ago

Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3

Indeterminate GlobeNewswire

9 hours ago

Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

9 hours ago

Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

9 hours ago

Altimmune Announces Third Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

9 hours ago

Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16

Indeterminate GlobeNewswire

9 hours ago

Immuneering Announces New Potentially Registrational Phase 2 Trial Evaluating Atebimetinib with Chemotherapy in Anaplastic Thyroid Cancer

Indeterminate GlobeNewswire

9 hours ago

Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update

Indeterminate GlobeNewswire

9 hours ago

Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

9 hours ago

Immuneering to Collaborate with Astellas on Clinical Studies of Investigational CLDN18.2 Programs in Combination with Atebimetinib for Pancreatic Cancer Patients

Indeterminate GlobeNewswire

9 hours ago

Vor Bio Expands Strategic Partnership with RemeGen, Adding Next Generation, Long-Acting RC298 to BAFF/APRIL Franchise

Indeterminate GlobeNewswire

9 hours ago

MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth

Indeterminate GlobeNewswire

9 hours ago

Dyadic’s C1-Produced RSV and Malaria Antibodies Advance into Animal Studies Following Positive Independent Evaluations

Indeterminate GlobeNewswire

9 hours ago

Ascendis Pharma Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire